Loenenbach Anna, Dudareva-Vizule S, Buder S, Sailer A, Kohl P K, Bremer V
Abteilung für Infektionsepidemiologie, Fachgebiet HIV/AIDS und andere sexuell oder durch Blut übertragbare Infektionen, Robert Koch-Institut, Seestraße 10, 13353, Berlin, Deutschland.
Konsiliarlabor für Gonokokken, Vivantes Klinikum Neukölln, Rudower Straße 48, 12351 Berlin, Deutschland.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Aug;58(8):866-874. doi: 10.1007/s00103-015-2191-9.
Recent years have seen a world-wide increase in antimicrobial resistance (AMR) in cases of infection with Neisseria gonorrhoeae (NG). NG infection is not notifiable in Germany and there is a lack of information available about the spread and AMR of NG infections. The objective of the study was to provide information on diagnostic methods and AMR testing in cases of NG infections in German laboratories. A cross-sectional survey was undertaken in Germany between June and August 2013 using an online questionnaire. Laboratories performing NG diagnostics were identified and described with regard to the diagnostic methods used, the number of tests performed, the antibiotics tested and the AMR observed, in addition to general laboratory information. In total, 188 of the 521 participating laboratories performed NG diagnostics; these were included in the further statistical analysis. 92.6 % of the 188 laboratories performed culture. A median of 60 (IQR 15-270) samples per quarter (SPQ) were tested, with an overall positivity rate of 4.1 and 6.9 % among men. Most (82.1 %) of the 151 laboratories performing NG culture tested for AMR as well. The most frequently tested antibiotics were ciprofloxacin (94.8 %), penicillin (93.1 %), doxycycline (70.0 %) and ceftriaxone (67.2 %). The most frequently observed AMR ever were those against ciprofloxacin (87.1 %), penicillin (78.3 %), doxycycline (56.6 %) and azithromycin (35.1 %; all percentages refer to laboratories). The laboratories used different standards regarding susceptibility criteria. The emergence and spread of AMR shows that it is crucial to assess and monitor the scope and trends of multidrug-resistant gonorrhea. The data collected on diagnostic methods and AMR testing in cases of NG infections in German laboratories constitute an important basis for future monitoring.
近年来,全球淋病奈瑟菌(NG)感染的抗菌药物耐药性(AMR)呈上升趋势。在德国,NG感染不属于法定报告疾病,因此缺乏有关NG感染传播和AMR的信息。本研究的目的是提供德国实验室中NG感染病例的诊断方法和AMR检测信息。2013年6月至8月间,在德国进行了一项横断面调查,采用在线问卷形式。除了一般实验室信息外,还对进行NG诊断的实验室进行了识别,并描述了其使用的诊断方法、检测数量、检测的抗生素以及观察到的AMR情况。在521家参与调查的实验室中,共有188家进行了NG诊断;这些实验室被纳入进一步的统计分析。188家实验室中有92.6%进行了培养。每季度检测样本的中位数为60份(四分位间距15 - 270),男性总体阳性率为4.1%和6.9%。在151家进行NG培养的实验室中,大多数(82.1%)也进行了AMR检测。检测频率最高的抗生素是环丙沙星(94.8%)、青霉素(93.1%)、多西环素(70.0%)和头孢曲松(67.2%)。最常观察到的AMR是对环丙沙星(87.1%)、青霉素(78.3%)、多西环素(56.6%)和阿奇霉素(35.1%;所有百分比均指实验室)的耐药。各实验室在药敏标准方面采用了不同的标准。AMR的出现和传播表明,评估和监测多重耐药淋病的范围和趋势至关重要。德国实验室收集的NG感染病例诊断方法和AMR检测数据构成了未来监测的重要基础。